首页> 外文期刊>Revista de Nefrologia Dialisis y Trasplante >Diabetes mellitus y nefropatía diabética en el Perú
【24h】

Diabetes mellitus y nefropatía diabética en el Perú

机译:秘鲁的糖尿病和糖尿病肾病

获取原文
       

摘要

Objectives: To describe the scientific literature production in Peru about type 2 diabetes mellitus (DM) and diabetic nephropathy (DN). Methods: A non-systematic review of the scientific production about DM and DN in peruvian population and has been published in national and international medical journals until february 2015 was conducted. We used the databases Medline, Web of Science, Scopus, SciELO and Google Scholar. The results?were divided a priori into 5 areas: Prevalence DM 2, clinical management of the diabetic patient, diagnosis of DN, risk factors for albuminuria,?and early assessment of DN. Results: We found 22 items. The prevalence of DM varies depending on the definition and study population and was higher on the coast than in the highlands (4.3% vs. 2.1%). In public hospitals in Lima, 40% of diabetic patients have HbA1c 7%. Likewise, the control of DM patients in Peru is poor compared with their Latin American counterparts. The “screening” of the NFD is uncommon, only 8.9% of patients have?albuminuria in their assessments in hospitals nationwide. Modifiable factors associated with albuminuria in patients with DN were found such as glucose (OR 1.19 95% CI 1.05 to 1.34), hypertension (OR 0.48 95% CI 0.33 to 0.70) and stages of chronic kidney disease OR: 93 (p = 0.007). There are hospitals where nephrology care in patients with DN is mostly under emergency conditions. Conclusions: The results of these articles reflect that there are aspects in the screening and management of both diseases that can be improved and scarcity of studies on the subject in Peru.
机译:目的:描述秘鲁有关2型糖尿病(DM)和糖尿病肾病(DN)的科学文献。方法:对秘鲁人群中DM和DN的科学生产进行非系统性综述,并已在国家和国际医学杂志上发表,直到2015年2月进行。我们使用了数据库Medline,Web of Science,Scopus,SciELO和Google Scholar。将结果分为5个领域:糖尿病的患病率DM 2,糖尿病患者的临床治疗,DN的诊断,白蛋白尿的危险因素以及DN的早期评估。结果:我们找到22个项目。糖尿病的患病率因定义和研究人群而异,沿海地区高于高原地区(4.3%比2.1%)。在利马的公立医院中,40%的糖尿病患者HbA1c> 7%。同样,秘鲁的DM患者与拉丁美洲的DM患者相比,控制能力较差。 NFD的“筛查”并不常见,在全国医院中只有8.9%的患者进行白蛋白尿评估。发现与DN患者白蛋白尿相关的可调节因素,例如葡萄糖(OR 1.19 95%CI 1.05至1.34),高血压(OR 0.48 95%CI 0.33至0.70)和慢性肾脏疾病的分期:OR:93(p = 0.007) 。在有些医院中,DN患者的肾脏病护理大多处于紧急情况下。结论:这些文章的结果反映出在秘鲁,这两种疾病的筛查和管理中有一些方面可以改善,但缺乏研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号